Johan Lokk

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. ncbi Drug and treatment costs in Parkinson's disease patients in Sweden
    J Lokk
    Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand 125:142-7. 2012
  2. ncbi [The only way to long life is to age]
    Johan Lokk
    Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet
    Lakartidningen 105:2396-7. 2008
  3. ncbi Reduced life-space of non-professional caregivers to Parkinson's disease patients with increased disease duration
    Johan Lokk
    Geriatric Dept, Institution of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital, SE 14186 Stockholm, Sweden
    Clin Neurol Neurosurg 111:583-7. 2009
  4. ncbi Dipyridamole-associated headache in stroke patients--interindividual differences?
    J Lokk
    Institution of Neurobiology, Caring Sciences and Society, Karolinska Institutet Geriatric Department, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Eur Neurol 62:109-13. 2009
  5. ncbi Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson's disease at a neurological outpatient clinic
    Johan Lokk
    Institution of Neurobiology, Care Sciences and Society, Karolinska Institutet, Geriatric Dept, Karolinska University Hospital Huddinge, SE 14186 Stockholm, Sweden
    Parkinsonism Relat Disord 16:540-4. 2010
  6. ncbi Caregiver strain in Parkinson's disease and the impact of disease duration
    J Lokk
    Institution of Neurobiology, Caring Sciences Society Karolinska Institutet, Stockholm, Sweden
    Eur J Phys Rehabil Med 44:39-45. 2008
  7. ncbi [Treatment with cabergoline in Parkinson disease can cause heart damage. Continuous treatment requires clinical and echocardiographic check ups]
    Johan Lokk
    Karolinska Universitetssjukhuset Huddinge
    Lakartidningen 104:2892-4. 2007
  8. ncbi ["Bamse" helps patients with Parkinson disease during the palliative phase. Alleviation of symptoms and respect for both the patient and the relatives are crucial]
    Johan Lokk
    Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska institutet geriatriska kliniken, Karolinska Universitetssjukhuset Huddinge, Stockholm
    Lakartidningen 104:124-7. 2007
  9. ncbi [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life]
    Johan Lokk
    Neurotecinstitutionen, Karolinska Institutet
    Lakartidningen 103:451-5. 2006
  10. ncbi [Breaking bad news--about the importance of correct information given in right time and in a right way]
    Johan Lokk
    NEUROTEC Institutionen, Karolinska Institutet, Stockholm
    Lakartidningen 102:2494-7. 2005

Detail Information

Publications22

  1. ncbi Drug and treatment costs in Parkinson's disease patients in Sweden
    J Lokk
    Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand 125:142-7. 2012
    ..Parkinson's disease (PD) is a chronic neurodegenerative disease expected to cause great costs. The aim of this study was to calculate drug and treatment costs in patients with PD in Sweden...
  2. ncbi [The only way to long life is to age]
    Johan Lokk
    Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet
    Lakartidningen 105:2396-7. 2008
  3. ncbi Reduced life-space of non-professional caregivers to Parkinson's disease patients with increased disease duration
    Johan Lokk
    Geriatric Dept, Institution of Neurobiology, Care Sciences and Society, Karolinska Institutet, Karolinska University Hospital, SE 14186 Stockholm, Sweden
    Clin Neurol Neurosurg 111:583-7. 2009
    ..To evaluate the impact of Parkinson's disease (PD) on unpaid, non-professional caregiver (CG) social relationships and related issues, as well as home-help services, over the time-course of the disease...
  4. ncbi Dipyridamole-associated headache in stroke patients--interindividual differences?
    J Lokk
    Institution of Neurobiology, Caring Sciences and Society, Karolinska Institutet Geriatric Department, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Eur Neurol 62:109-13. 2009
    ..However, there are no studies on interindividual differences in the incidence of headache with regard to age, gender, localization of stroke and the number of days since stroke onset...
  5. ncbi Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson's disease at a neurological outpatient clinic
    Johan Lokk
    Institution of Neurobiology, Care Sciences and Society, Karolinska Institutet, Geriatric Dept, Karolinska University Hospital Huddinge, SE 14186 Stockholm, Sweden
    Parkinsonism Relat Disord 16:540-4. 2010
    ..In this study, we aimed to investigate the frequency, type and factors associated with the use of CAM in Parkinson's disease (PD) patients at a neurological outpatient clinic...
  6. ncbi Caregiver strain in Parkinson's disease and the impact of disease duration
    J Lokk
    Institution of Neurobiology, Caring Sciences Society Karolinska Institutet, Stockholm, Sweden
    Eur J Phys Rehabil Med 44:39-45. 2008
    ..The aim of this study was to evaluate CG strain of PD patients with regarding different psychosocial domains and the influence of PD/CG duration of PD...
  7. ncbi [Treatment with cabergoline in Parkinson disease can cause heart damage. Continuous treatment requires clinical and echocardiographic check ups]
    Johan Lokk
    Karolinska Universitetssjukhuset Huddinge
    Lakartidningen 104:2892-4. 2007
  8. ncbi ["Bamse" helps patients with Parkinson disease during the palliative phase. Alleviation of symptoms and respect for both the patient and the relatives are crucial]
    Johan Lokk
    Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska institutet geriatriska kliniken, Karolinska Universitetssjukhuset Huddinge, Stockholm
    Lakartidningen 104:124-7. 2007
  9. ncbi [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life]
    Johan Lokk
    Neurotecinstitutionen, Karolinska Institutet
    Lakartidningen 103:451-5. 2006
  10. ncbi [Breaking bad news--about the importance of correct information given in right time and in a right way]
    Johan Lokk
    NEUROTEC Institutionen, Karolinska Institutet, Stockholm
    Lakartidningen 102:2494-7. 2005
  11. ncbi Stroke epidemiology and one-month fatality among an urban population in Iran
    Ahmad Delbari
    Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    Int J Stroke 6:195-200. 2011
    ..Stroke is one of the most common causes of death and disability in Iran. This study evaluated stroke patient profiles with respect to rate, risk factors, and one-month fatality...
  12. ncbi Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial
    Ahmad Delbari
    Department of Neurobiology, Care Sciences and Society, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
    Eur Neurol 66:7-13. 2011
    ..We sought to prospectively study the effects of levodopa (LD) and/or methylphenidate (MPH) in combination with physiotherapy on mood and cognition following stroke in human subjects...
  13. ncbi A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine
    Sylvia Annerbo
    Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
    Dement Geriatr Cogn Disord 28:275-80. 2009
    ..Our objective was to prospectively investigate the association between tHcy and TSH and the subsequent development of AD...
  14. ncbi [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure]
    Johan Lokk
    Neurotec institutionen och geriatriska kliniken, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge
    Lakartidningen 101:2003-6. 2004
    ..We describe the use of memantine on three cognitively impaired, dyskinetic Parkinsonian patients where two seemed to benefit from this medication regarding their dyskinesia...
  15. ncbi Work site change and psychosocial well-being among health care personnel in geriatric wards--effects of an intervention program
    Johan Lokk
    Department of Clinical Neuroscience, Occupational Therapy and Elderly Care Research, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
    J Nurs Care Qual 16:30-8. 2002
    ..In order to achieve successful organizational change, psychosocial intervention programs for personnel must be performed by a well-informed, well-chosen, and experienced counsellor who is well tailored to the local organization...
  16. ncbi Clinical aspects of palliative care in advanced Parkinson's disease
    Johan Lokk
    Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatric, Huddinge Hospital, R94, Karolinska Institute, Stockholm, Sweden, SE 141 86
    BMC Palliat Care 11:20. 2012
    ..The purpose of this review is to provide a summary of the palliative care management issues and palliative care management options of end-stage PD patients...
  17. ncbi [Clinical supervision--a difficult art]
    Johan Lokk
    NEUROTEC Institutionen, Karolinska Institutet, Geriatriska kliniken, Huddinge Universitetssjukhus
    Lakartidningen 99:2968-9. 2002
  18. ncbi A stroke study of an urban area of Iran: risk factors, length of stay, case fatality, and discharge destination
    Ahmad Delbari
    Department of Neurobiology, Care Sciences and Society, Geriatric Division, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden
    J Stroke Cerebrovasc Dis 19:104-9. 2010
    ....
  19. ncbi Management of depression in elderly stroke patients
    Johan Lokk
    Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden
    Neuropsychiatr Dis Treat 6:539-49. 2010
    ..Cognitive behavioral therapy can also be useful, and electroconvulsive therapy is available for patients with severe refractory PSD...
  20. ncbi [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels]
    Johan Lokk
    Geriatriska kliniken NEUROTEC institutionen, sektionen för geriatrik, Karolinska Institutet, Huddinge Universitetssjukhus, Stockholm
    Lakartidningen 100:2674-7. 2003
    ..An increase in homocysteine levels and tissue deficiency of vitamin B12 and folate may occur. The responsible doctor should be liberal in checking vitamin B12 and folate status and supplement with appropriate vitamins when needed...
  21. ncbi An education programme for individuals with Parkinson's disease
    H Sunvisson
    Department of Clinical Neuroscience, Occupational Therapy, and Elderly Care Research, Division of Geriatric Medicine, Karolinska Institutet, Sweden
    Scand J Caring Sci 15:311-7. 2001
    ..However, these improvements were not transferred to habitual daily life, which suggests that task-oriented training provides the best solution...
  22. ncbi Shifts in B12 opinions in primary health care of Sweden
    J Lokk
    Department of Clinical Neuroscience, Karolinska Institute Huddinge Hospital, Stockholm, Sweden
    Scand J Public Health 29:122-8. 2001
    ..Most patients with B12-associated problems are managed in primary health care by general practitioners (GPs)...